#United States #Boise #GT Medical Technologies #GammaTile® #St. Luke’s Boise

GT Medical Technologies Recognizes St. Luke's Boise Medical Center

On October 6, 2026, GT Medical Technologies officially announced its latest designation of a GammaTile® Center of Excellence, awarding this honor to St. Luke's Boise Medical Center. This program is pivotal in recognizing medical centers and practitioners who excel in patient care and display advanced capabilities in administering the GammaTile® procedure.

What is GammaTile®?

GammaTile® is an innovative form of radiation therapy that is uniquely designed for use at the same time as tumor removal surgery. This technique delivers immediate and localized radiation treatment directly to the tumor site as soon as the tumor is excised, which is instrumental in targeting residual cancer cells that may otherwise go untreated if conventional methods are applied. Unlike standard procedures, which typically involve a waiting period between surgery and radiation to allow for healing, GammaTile provides real-time treatment, thereby maximizing the potential effectiveness of the therapy and minimizing the likelihood of tumor regrowth.

The therapy is particularly significant for patients with malignant brain tumors, enhancing the standard protocol by improving the immediacy of care. This step forward in brain tumor management not only signifies progress in medical technology but also underlines GT Medical Technologies' commitment to elevating the standard of care for patients confronting these challenges.

Recognized Physicians

The Center of Excellence designation brings focus to a team of skilled physicians at St. Luke's, who are now recognized for their exceptional practice and dedication in performing the GammaTile® procedure:

• - Edward A. Duckworth, MD - Expert in Cranial Surgery, Neurointerventional Surgery, Neurosurgery, and Skull Base Surgery.
• - David P. Bray, MD - Specializes in Cranial Surgery and Neurosurgery.
• - Derek L. Martinez, MD - Neurosurgery specialist.
• - Benjamin G. McGahan, MD - Focused on Neurosurgery.
• - Cameron S. Thorpe, MD - A professional in Radiation Oncology.
• - Tonya L. Kuhn, MD - Expert in Radiation Oncology.
• - Stephen C. Smith, MD - Experienced in Radiation Oncology.
• - Timothy E. Sawyer, MD - Specialized in Radiation Oncology.
• - Amy Geyer, MS - A Medical Physicist contributing expertise to the team.

This recognition not only establishes these physicians as leading experts in their field but also assures patients that they are receiving care from a highly qualified and dedicated team.

Influence and Reach

GammaTile® has gained significant traction since its introduction, having been deployed in over 150 leading medical centers across the United States. Its FDA clearance for both newly diagnosed malignant and recurrent brain tumors has been a turning point in cancer treatment protocols, further ensuring its growing acceptance within both academic and community healthcare settings. The encouragement for ongoing education and maintaining strict clinical criteria ensures that designated centers like St. Luke's Boise Medical Center continually enhance their practices and remain at the forefront of brain tumor treatment methodologies.

With advancements such as these, GT Medical Technologies is making considerable strides to improve the lives of patients battling brain tumors. Their focus on innovative problem-solving positions them strategically in the healthcare landscape, shedding light on significant innovations that redefine patient care practices.

For more insights into GammaTile® and its impact on brain tumor treatment, follow @GammaTile on social media platforms like Facebook, Instagram, LinkedIn, and X. For comprehensive information, prospective patients and healthcare providers can visit gammatile.com.

Conclusion

The designation of St. Luke's Boise Medical Center as a GammaTile® Center of Excellence is a testament to their outstanding leadership in patient education and the exemplary clinical skills exhibited in the implementation of the GammaTile procedure. This initiative not only revolutionizes the immediate care of brain tumor patients but also establishes a new benchmark in therapeutic practices within the medical community.